- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 31/00 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patent holdings for IPC class A61P 31/00
Total number of patents in this class: 6543
10-year publication summary
|
251
|
356
|
506
|
427
|
525
|
490
|
448
|
346
|
290
|
218
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 310 |
275 |
| Bristol-myers Squibb Company | 4757 |
62 |
| The Regents of the University of California | 20902 |
43 |
| Centre National de La Recherche Scientifique | 11111 |
34 |
| Agency for Science, Technology and Research | 3765 |
26 |
| The Johns Hopkins University | 5938 |
24 |
| F. Hoffmann-La Roche AG | 7798 |
23 |
| The General Hospital Corporation | 4890 |
22 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3303 |
22 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3015 |
22 |
| The University of North Carolina at Chapel Hill | 2120 |
22 |
| Boehringer Ingelheim International GmbH | 4479 |
21 |
| Merck Patent GmbH | 5747 |
21 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3324 |
21 |
| Novartis AG | 10169 |
19 |
| Pfizer Inc. | 3418 |
19 |
| President and Fellows of Harvard College | 6115 |
19 |
| Merck Sharp & Dohme Corp. | 2183 |
18 |
| Takeda Pharmaceutical Company Limited | 2700 |
17 |
| Hoffmann-La Roche Inc. | 3841 |
16 |
| Other owners | 5797 |